Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

The document's conclusion cannot be determined from the provided text.

Abrocitinib may effectively treat Lichen Planopilaris.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Naproxen effectively treated a girl's eosinophilic pustular folliculitis when other treatments failed.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Clofazimine effectively treated ashy dermatosis in a patient.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Co-trimoxazole may help treat autoimmune diseases.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

MG53 helps reduce skin damage caused by nitrogen mustard.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Talquetamab may cause hair loss and skin issues.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

A new therapy for a skin blistering condition has not been developed yet.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Scalp pemphigus vulgaris can be effectively treated with low-dose prednisone and triamcinolone.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Dupilumab helps children with alopecia areata regrow hair safely.

Dupilumab can both heal and cause hair loss.